Enerpac Tool Group Corp. (EPAC) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call revealed positive aspects such as a shift to higher-margin services, strong R&D investment, and solid growth in Cortland Biomedical. The Q&A section highlighted strategic moves to enhance service value and product innovation, despite some market softness and unclear details on certain initiatives. The company's positive guidance, increase in free cash flow, and low net debt-to-EBITDA ratio further support a positive outlook. Given the market cap, the stock price is likely to react positively, but not overwhelmingly, resulting in a 'Positive' prediction (2% to 8%).
Key Financial Performance
Revenue Enerpac's first quarter revenue of $144 million decreased 1% year-over-year. The decline was attributed to a 3% organic decline in IT&S sales, offset by a 4% increase in product revenue.
Product Revenue Product revenue increased 4% year-over-year. Standard products were up low single digits, and the Heavy Lifting Technology business experienced double-digit growth due to capturing additional applications in the infrastructure end market.
Service Revenue Service revenue declined 26% year-over-year, primarily in the EMEA region, particularly in the U.K., due to lower production and customer consolidation in the oil and gas industry.
Gross Profit Margin Gross profit margin was 50.7%, consistent with recent quarters. Margins were impacted by higher tariff-driven costs, which were offset by pricing and productivity actions. A favorable mix shift was offset by lower service margins.
Adjusted EBITDA Adjusted EBITDA was $32.4 million, representing a margin of 22.4%. This was impacted by flat year-over-year SG&A spending, which offset inflationary compensation and incremental innovation spending.
Adjusted Earnings Per Share (EPS) Adjusted EPS was $0.36, down from $0.40 in the prior year. A higher effective tax rate negatively impacted earnings by $0.02 per share.
Net Debt Net debt was $49 million at quarter end, resulting in a net debt to adjusted EBITDA ratio of 0.3.
Free Cash Flow Free cash flow was $13 million, an increase of $10 million year-over-year. This increase was due to the timing of receipts and payments in the quarter, as well as lower capital expenditures compared to the prior year.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Product Introductions: Increased spending on innovation to deliver more new product introductions in fiscal 2026.
Specialized Tensioners: Enerpac sells a line of specialized tensioners under the Biach name, which are industry standards for refueling and inspection in the nuclear industry.
Geographic Expansion: Expanding sales capabilities, coverage, and distribution in India, Australia, and the Philippines.
Infrastructure and Power Generation: Strong demand from infrastructure and power generation markets, including significant contract wins for bridge and tunnel projects.
Operational Efficiencies: Implemented Enerpac Commercial Excellence (ECX) for improved sales process and funnel management.
E-commerce Enhancement: Implementation of a new technology platform to improve user experience and provide sophisticated marketing and analytical tools.
Strategic Growth Initiatives: Refined growth strategy and updated strategic growth initiatives during the Annual Global Leadership Conference.
Focus on Key Verticals: Targeting growth in power generation and infrastructure markets, leveraging specialized products and services.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Service Revenue Decline in EMEA: Service revenue in the EMEA region declined by 26%, primarily due to lower production and customer consolidation in the oil and gas industry, particularly in the U.K. This slowdown poses a challenge to the company's service operations in the region.
Economic Conditions in EMEA: Revenue in the EMEA region declined by 10%, attributed to underlying economic conditions. This region has been described as a 'wildcard' for fiscal 2026, indicating uncertainty and potential risk to performance.
Political Uncertainty in Southeast Asia and Slowdown in China: The APAC region experienced an 8% revenue decline, driven by political uncertainty in Southeast Asia and a slowdown in China, which negatively impacted performance.
Tariff-Driven Cost Pressures: Gross profit margins were affected by higher tariff-driven costs, which flowed through the cost of goods sold. Although partially offset by pricing and productivity actions, this remains a challenge.
Lower Service Margins: Service margins were lower, which offset favorable mix shifts within the portfolio, impacting overall profitability.
Higher Effective Tax Rate: A higher effective tax rate negatively impacted earnings per share by $0.02, reducing overall profitability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Organic Revenue Growth: Maintaining full-year fiscal 2026 guidance with expectations of organic revenue growth of 1% to 4%.
Adjusted EBITDA Growth: Projected growth of 6% at the midpoint for fiscal 2026.
Free Cash Flow: Expected to be between $100 million to $110 million for fiscal 2026.
Earnings Per Share: Guidance for fiscal 2026 is $1.85 to $2 per share.
APAC Region Growth: Anticipates year-over-year growth resuming in the second quarter and for the full fiscal year, driven by strength in India, recovery in Australia, and a strong Heavy Lifting Technology (HLT) funnel.
Gross Profit Margin: Margin pressure from tariffs expected to ease in the second half of fiscal 2026.
Innovation and Product Launches: Increased spending on innovation with expectations of delivering more new product introductions in fiscal 2026.
E-commerce Capability: Implementation of a new technology platform to enhance user experience and improve marketing and analytical tools, aiming for higher conversion rates.
Market Trends: Strong demand expected from infrastructure, defense, and power generation markets, including opportunities in nuclear energy and AI data centers.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Stock Repurchase: Enerpac repurchased $15 million of stock in the first quarter of fiscal 2026 as part of its balanced capital allocation strategy.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What caused a sudden sharp decline in service revenue this quarter?
A:The decline was largely driven by a contraction in the U.K. market. The company passed on lower-margin projects as part of its strategy to capture higher-margin service business. However, due to consolidation and softness in the oil and gas market, they have not yet backfilled this with more profitable business, particularly in the U.K. market.
Q:What changes are being made in services to capture higher-value business?
A:The company is transitioning from an agent-based model to a direct-based model in multiple markets, which allows for direct customer relationships, more follow-on business, and higher margins. They are also investing in field service capabilities, capital equipment, and tools, such as in the European leak sealing business, to capture more growth opportunities and market share.
Q:What is the pricing strategy heading into calendar year 2026?
A:The company implemented a small low single-digit price increase in early December, which will take time to roll through the channel due to notice periods. They aim to maintain margin targets by balancing price and productivity.
Q:What is contributing to the 2026 organic growth guidance?
A:The guidance includes contributions from new product launches, with the company targeting nearly double the number of launches compared to fiscal '25. Investments in R&D and innovation, including a new innovation lab, are also driving growth. The company aims to outperform its peers through these efforts.
Q:What is the trajectory for R&D growth and its impact on long-term growth?
A:The company has a multiyear innovation funnel and plans to nearly double new product launches in fiscal '26 compared to fiscal '25. R&D spend has been increasing incrementally over the past three years, and the company expects a consistent ramp in R&D growth to drive top-line growth and outperform competitors.
Q:What is the visibility into the R&D funnel and its robustness?
A:The company has a multiyear innovation funnel and is updating it annually. They launched 5 new products in fiscal '25 and aim to nearly double that in fiscal '26, reflecting investments and new processes to accelerate innovation.
Q:What is the current state of the backlog and its impact on confidence in the outlook?
A:The company is not heavily reliant on backlog but has seen an increase due to strong order activity, which outpaced revenue growth in the quarter. This has increased confidence in the full-year outlook.
Q:What is the pricing action taken in December and its scope?
A:The pricing action was a low single-digit increase applied to product sales in the Americas and Europe. It does not apply to the total portfolio, only to product sales.
Q:What is the growth and performance of the Cortland business?
A:Cortland Biomedical, a $20 million annual revenue business, is experiencing strong growth and high margins. It designs and manufactures custom biomedical textile fibers for medical devices, making it a sticky and long-cycle business. The company has won new commercial opportunities, driving revenue growth.
Q:What is the status of inventory and its impact on Q2?
A:Inventory is up about 15% to support strong Q2 order rates, which outpaced product revenue growth in Q1. The company is optimistic about Q2 performance.
Q:What is the status of M&A activity and its outlook?
A:M&A activity has picked up considerably in the last quarter or two. The company is actively evaluating several opportunities and remains disciplined in its approach, focusing on creating value for shareholders.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the exact timeline for backfilling lower-margin projects with higher-margin business in the U.K. market. Additionally, while they mentioned a multiyear innovation funnel and plans to nearly double product launches, they did not provide specific numerical targets or examples of the new products. Similarly, the exact size of the backlog and its breakdown by product or region were not disclosed. Lastly, while discussing M&A activity, no specific companies or sectors being targeted were mentioned.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
APAC decline
Americas expansion
Asia slowdown
Australia HLT
Capital expenditure
China drag
Cortland gain
DTA Enerpac
EMEA opportunity
EMEA product
Enerpac Cortland
Enerpac Tool
Enerpac position
Enerpac sale
Europe APAC
Group Instructions
HLT funnel
HLT uncertainty
India recovery
Industrial Tools
Instructions Williams
Relations Enerpac
Relations Senior
Service timing
Services segment
Slide Enerpac
Slide expectation
Southeast Asia
Technology application
Tools Services
UK market
Williams Senior
ability market
action margin
allocation stock
increase
period
service EMEA
strength infrastructure
trend
EPAC Transcript
Enerpac Tool Group Corp. (EPAC) Q2 2026 Earnings Call Transcript
Positive3-26
The earnings call highlights strong organic sales growth in the Industrial Tools & Service segment, marking the highest product growth experienced by the company. This is a strong positive indicator, despite risks mentioned in forward-looking statements. The absence of any significant negative feedback or unclear responses in the Q&A further supports a positive sentiment. Given the company's market cap, the stock price is likely to see a positive movement of 2% to 8% over the next two weeks.
Enerpac Tool Group Corp. (EPAC) Q1 2026 Earnings Call Transcript
Positive12-18
The earnings call revealed positive aspects such as a shift to higher-margin services, strong R&D investment, and solid growth in Cortland Biomedical. The Q&A section highlighted strategic moves to enhance service value and product innovation, despite some market softness and unclear details on certain initiatives. The company's positive guidance, increase in free cash flow, and low net debt-to-EBITDA ratio further support a positive outlook. Given the market cap, the stock price is likely to react positively, but not overwhelmingly, resulting in a 'Positive' prediction (2% to 8%).
Enerpac Tool Group Corp. (EPAC) Q4 2025 Earnings Call Transcript
Positive10-16
Despite challenges in the EMEA market, the company showed strong growth in adjusted EBITDA and EPS, and maintained a solid cash flow. The DTA integration is progressing well, and the global rollout of e-commerce is promising. The optimistic guidance for fiscal '26, strong M&A outlook, and a $200 million share repurchase program further support a positive sentiment. However, the cautious growth outlook and macroeconomic uncertainties temper expectations, resulting in a positive but not strong positive prediction.
Enerpac Tool Group Corp. (EPAC) Q3 2025 Earnings Call Transcript
Unknown6-27
The earnings call highlights strong organic sales growth and positive reception of new products, but is tempered by concerns over slightly declining EBITDA margins and restructuring costs. The Q&A reveals management's cautious stance on M&A and tariff impacts, with some uncertainty in financial guidance. Given the market cap, these mixed signals suggest a neutral stock price reaction.
EPAC Slides
EPAC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
